Tocilizumab therapy in individuals with COVID‐19 infection and hyperinflammatory state

Documenti analoghi

• The COVIRL002 Trial-Tocilizumab for management of severe, non-critical COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial
  di: Cotter, Aoife, et al.
  Pubblicazione: (2020)
• The COVIRL-001 Trial: A multicentre, prospective, randomised trial comparing standard of care (SOC) alone, SOC plus hydroxychloroquine monotherapy or SOC plus a combination of hydroxychloroquine and azithromycin in the treatment of non- critical, SARS-CoV-2 PCR-positive population not requiring immediate resuscitation or ventilation but who have evidence of clinical decline: A structured summary of a study protocol for a randomised controlled trial
  di: Feeney, Eoin, et al.
  Pubblicazione: (2020)
• Remote monitoring of oxygen saturation in individuals with COVID-19 pneumonia
  di: O'Carroll, Orla, et al.
  Pubblicazione: (2020)
• A Case of Fournier’s Gangrene Secondary to Varicella Zoster Virus in a 7-Year-Old Boy
  di: Eimear Phoenix, et al.
  Pubblicazione: (2025-01-01)
• Prevalence of comorbid asthma in COVID-19 patients
  di: Butler, Marcus W., et al.
  Pubblicazione: (2020)